90770166

Information

  • Trademark
  • 90770166
  • Serial Number
    90770166
  • Filing Date
    June 11, 2021
    3 years ago
  • Transaction Date
    September 13, 2024
    2 months ago
  • Status Date
    September 12, 2024
    2 months ago
  • Published for Opposition Date
    August 30, 2022
    2 years ago
  • Location Date
    October 25, 2022
    2 years ago
  • Status Code
    733
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    LAMONT, JOHN
  • Attorney Docket Number
    144488341578
    Attorney Name
    Jessica L. Rothstein
    Law Office Assigned Location Code
    N50
  • Owners
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of of stylized nucleic acid double helix.
  • GS0051: Pharmaceuticals, namely, preparations for the treatment of infections, cancer, and autoimmune diseases; pharmaceuticals using genetic code to target and treat diseases in humans, namely, preparations for the treatment of infections, cancer, and autoimmune diseases
  • GS0441: Providing information in the fields of medicine, pharmaceuticals and therapeutics
  • GS0421: Research, development in the medical, pharmaceutical and biotechnology fields; research and development in the field of the biosphere, fungi, pharmaceuticals and therapeutics
Case File Event Statements
  • 6/15/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/1/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/2/2021 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 12/7/2021 - 2 years ago
    4 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/7/2021 - 2 years ago
    5 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/7/2021 - 2 years ago
    6 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/2/2022 - 2 years ago
    9 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/2/2022 - 2 years ago
    7 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/2/2022 - 2 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/2/2022 - 2 years ago
    10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/20/2022 - 2 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/20/2022 - 2 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/20/2022 - 2 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/22/2022 - 2 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/10/2022 - 2 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/30/2022 - 2 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/30/2022 - 2 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/25/2022 - 2 years ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/22/2023 - a year ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/22/2023 - a year ago
    21 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 4/22/2023 - a year ago
    20 - SOU EXTENSION 1 FILED Type: EXT1
  • 9/25/2023 - a year ago
    24 - SOU EXTENSION 2 FILED Type: EXT2
  • 9/25/2023 - a year ago
    25 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 3/19/2024 - 8 months ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 3/19/2024 - 8 months ago
    28 - SOU EXTENSION 3 FILED Type: EXT3
  • 4/25/2023 - a year ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/25/2023 - a year ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 9/27/2023 - a year ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 3/19/2024 - 8 months ago
    29 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 9/12/2024 - 2 months ago
    31 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 9/12/2024 - 2 months ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/12/2024 - 2 months ago
    32 - SOU EXTENSION 4 FILED Type: EXT4
  • 9/12/2024 - 2 months ago
    33 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 3/20/2024 - 8 months ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA